Innovative Diagnostics for Public Health

InBios International Inc. specializes in the design, development and manufacture of diagnostic devices for emerging infectious diseases and biothreats. Founded in 1996 in Seattle, WA, our superior quality products are accurate, easy to use and cost effective.

InBios offers an extensive catalog of life science reagents, along with a portfolio of more than 25 diagnostic products, including FDA-cleared ELISA kits for Zika, dengue, and West Nile and rapid test kits for Chagas and leishmaniasis. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified.

Read More

First EUA for ELISA Detecting IgM Antibodies

Available Now for Purchase: US FDA Emergency Use Authorized InBios continues to add to its COVID-19 product line with the SCoV-2 Detect™ IgM ELISA Kit, an in vitro diagnostic test that has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). This marks the first EUA granted for an ELISA that specifically detects IgM antibodies to SARS-CoV-2 in human serum.

Check our COVID-19 page frequently for updates.

Click on the button below to be added to our mailing list for the latest updates.

Sign Up for InBios Email

Conference Exhibitions

InBios in the News


Zika   •   Chikungunya   •   Dengue   •   West Nile   •   Japanese Encephalitis   •   Scrub Typhus   •   Visceral Leishmaniasis   •   Cutaneous Leishmaniasis   •   Chagas   •   Filariasis   •   Strongyloides   •   Leptospirosis   •   Melioidosis   •   Norovirus

Current Newsletter
View Past Newsletters
Sign Up for InBios Email